Thursday, 11 June 2026European Markets

#pharmaceutical regulation

2 articles

Tafoxiparin Licensing Deal Faces EU Approval Uncertainty as Exeltis Awaits Market Authorization

EU Pharmaceutical Regulation

Tafoxiparin Licensing Deal Faces EU Approval Uncertainty as Exeltis Awaits Market Authorization

ViaNews Editorial Team (Europe)•Feb 21, 2026

European Pharma in Flux: Orion Bets on R&D Growth as Global Restructuring Reshapes EU Drug Pipelines

Pharmaceutical Regulation

European Pharma in Flux: Orion Bets on R&D Growth as Global Restructuring Reshapes EU Drug Pipelines

ViaNews Editorial Team (Europe)•Feb 18, 2026